EQ001

· Equillium, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EQ001, covering 2025-04-18 to 2025-04-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD [Phase 1, Phase 2]

See pricing